Skip to content
★ Sign in to follow
KE

Katharine E. Spink

Executive
Asterias Biotherapeutics, Inc.Geron Corp
Total declarations
34
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€277k

Latest filing published 07 Jun 2017 for Asterias Biotherapeutics, Inc., €21k.

Filing timeline

BuySale
Katharine E. Spink

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Katharine E. Spink: trading record in brief

Filings by Katharine E. Spink span 2 companies, the busiest being Asterias Biotherapeutics, Inc. and Geron Corp. Between 26 May 2009 and 5 June 2017, the trades on record add up to 34 filings.

Sales make up the whole of the open-market record (14 sales, €277k). Outside the open market, there are 16 share grants and 3 option exercises. 2017 to date brings no purchases and 2 sales.

The latest filing, published on 7 June 2017, reports a share grant of €21k in Asterias Biotherapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Katharine E. Spink

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total

25 of 34 declarations